|
|
Volumn 14, Issue 8, 2015, Pages 513-515
|
|
NCI-MATCH trial pushes cancer umbrella trial paradigm
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER GENETICS;
CANCER SURVIVAL;
CLINICAL PROTOCOL;
CLINICAL STUDY;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
GENE MUTATION;
GENETIC VARIABILITY;
HEALTH CARE COST;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
PRIORITY JOURNAL;
SHORT SURVEY;
STUDY DESIGN;
TREATMENT PLANNING;
TREATMENT RESPONSE;
GENETIC SCREENING;
GENETICS;
MASS SCREENING;
MOLECULARLY TARGETED THERAPY;
NATIONAL HEALTH ORGANIZATION;
NEOPLASMS;
PROCEDURES;
UNITED STATES;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
GENETIC TESTING;
HUMANS;
MASS SCREENING;
MOLECULAR TARGETED THERAPY;
NATIONAL CANCER INSTITUTE (U.S.);
NEOPLASMS;
UNITED STATES;
|
|
EID: 84938299874
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4694 Document Type: Short Survey |
|
Times cited : (68)
|
|
References (0)
|
